- Benchmark ASINB0F8BSQWJC
- MarketplaceUS
- Category ID7792528011
- Analyzed Products
- Keywordface moisturizer
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-30
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，结论很明确：已经进入价格战区，而且新品牌几乎没有稳定成功路径。 现有样本里，新发布产品只有16.67%盈利；按新品牌看，5个新品牌里只有MAREE跑通，成功率20.00%，其余80.00%全部失败。更关键的是，最近一批进入者几乎是清一色失手，市场正在变得更难而不是更容易。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很直接：这个市场不适合进入。 现在不是“预算够不够”的问题，而是市场本身已经呈现明显的低成功率和价格/利润压力：新品牌新上架盈利率只有16.67%，整体可识别样本里盈利率也只有30.77%，同时近几个月新增上架几乎全是亏损项，2026年1月到4月连续出现 MESANDY、SKIN DEVA、WELLAGE、Neutrogena、Olay 的失败新款，说明入场后很容易被卷进低利润竞争。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?16.66%New listing success rate (old brands):0.00%New listing success rate (new brands):20.00%Which new brands have these successful new listings?Alternatives- 保湿面霜替代：如果用户只是想要“补水不紧绷”，可用更基础的无香型润肤霜/身体乳薄涂到面部，通常更便宜、容量更大、购买更容易，适合预算敏感人群。
- 凡士林/矿脂封层替代：在面霜前后少量使用凡士林、矿脂软膏或修护膏做封闭保湿，成本很低，尤其适合夜间干燥、屏障受损时做临时替代。
- 保湿喷雾+简化乳液组合：用便宜的保湿喷雾或纯净水打湿后叠加基础乳液，能快速获得“短期缓解干燥”的效果，入门门槛低，也方便在办公室/出行中使用。
- 药房基础修护乳替代：选择药房常见的神经酰胺/甘油/尿素类修护乳，而不是高活性精华或高端面霜；这类产品通常更稳定、更少刺激，适合想要降低试错成本的用户。
- 洁面后直接湿敷/压水法：如果用户购买面霜主要是为了‘立刻不干’，可先用低成本湿敷或拍水再上少量乳液，属于更省钱的临时方案，尤其适合轻度缺水场景。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不适合进入，结论很明确：已出现明显价格战/饱和信号，新品牌成功率低，继续投入风险大。 目前样本里可识别的盈利产品只有30.77%，而新上架产品里只有16.67%盈利；更关键的是，新品牌新上架里盈利率只有20%，非盈利率却高达80%，说明新玩家大多难以跑通。
Most investment in new productsNew products with Highest revenueLeast investment in new productsMAREE
Recent Monthly Revenue (USD):$3,936.00(400pcs/month)B0G2CKD7M9 (4.3/5 (414 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableOld brand with the most profitable new productsMederma
Recent Monthly Revenue (USD):$96,150.00(5000pcs/month)B0F8BSQWJC (4.5/5 (292 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableLeast profitable new productsMESANDY
Recent Monthly Revenue (USD):-(-)B0GR3445HGBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 粉色圆润瓶身+金色滴管，画面更吸睛，偏高端护肤感
- |
- PDRN鲑鱼DNA、肽、视黄醇等复合卖点，和常规精华区分明显
- |
- 主打玻璃肌、抗老提亮，年轻护肤人群更容易点击
B0G2CKD7M9 (4.3/5 (414 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 针对旧疤痕修护，功能非常独特，不像普通保湿精华
- |
- 品牌认知强，临床可见效果表达明确，更容易促成点击
- |
- 包装是药膏/修护凝胶风格，与其他面部精华外观差异大
B0F8BSQWJC (4.5/5 (292 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不适合进入，结论很明确：已接近/进入价格战区，且新品端没有形成可复制的健康盈利模型。 新品牌里只有 MAREE 这一家新品牌新品赚钱，而且利润率只有 11.3%，刚刚越过及格线；其余新品牌新品全部亏损或暂时不成功，说明小品牌想靠正常打法切入，成功率非常低。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0F8BSQWJCMederma2025-05-12Yes$19.235000pcs$96150.031.42%$30210.33B08936CZHQNeutrogena2020-07-04Yes$27.742000pcs$55480.036.25%$20111.5
B0CHZ1FHZMSoena2023-10-31Yes$17.17200pcs$3434.028.26%$970.45B0G2CKD7M9MAREE2025-12-20Yes$9.84400pcs$3936.011.32%$445.56Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0G2CKD7M9MAREE2025-12-20Yes$9.84400pcs$3936.011.32%$445.56#New Product Success Rates
Listing这个市场不适合进入，整体已经偏饱和，而且是明显的价格战/低壁垒市场。 新品成功率只有16.67%，但这1个成功样本来自MAREE，靠的是低价+功能差异化；其余83.33%的新品都不赚钱。更关键的是，老品牌几乎全面压制新进入者：新品牌里真正赚钱的只有MAREE，失败的新品牌包括MESANDY、SKIN DEVA、WELLAGE，说明普通新品牌很难靠常规打法活下来。
证据很直接：市场里可识别的盈利产品占30.77%，但新品盈利只剩16.67%，老品牌新品盈利更是0%。 收入样本里，Mederma 的 B0F8BSQWJC 月收入约 96,150 美元、Neutrogena 的 B08936CZHQ 约 55,480 美元，说明头部老牌吃掉了最强的利润位；反过来，Hicream 的 B0CMTP5FLJ 只有 9.8% 利润率，月收入约 1,858 美元，典型的低毛利竞争。用户预算 500,000 元人民币看起来够做单个 ASIN 的前期启动，但这类市场不是“能不能起步”的问题，而是“起步后能不能打过老牌和价格战”的问题；从现有数据看，普通小商家没有稳定的合法成功路径，若要硬进，往往会被迫依赖强营销甚至偏激进投放，风险很高。
结论：不要进。 如果一定要学，只有两条样板：大品牌看 Mederma / Soena 这种靠品牌力和成熟产品线的打法；小商家只看 MAREE 的 B0G2CKD7M9，它是少数真正的新品牌盈利样本，但也明显依赖低价与功能差异化，不是容易复制的路径。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
MAREENonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
NeutrogenaMESANDYSKIN DEVAOlayWELLAGE#Success Rate by Entry Time
Listing这个市场不值得进入，结论很明确：新品牌几乎打不动，已经接近价格战+高失败率组合。 目前可见的新品牌里，只有 MAREE 的 B0G2CKD7M9 进入了真正可盈利状态，另外 4 个新品牌新款都没跑通；新发布成功率只有 16.67%，而新品牌样本里成功率只有 20%，这已经是明显偏危险的信号。
从时间趋势看，市场不是在变容易，而是在变难：2025 年只看到 2 个新发布，1 个盈利、1 个不盈利；到了 2026 年已经出现 4 个新发布全部不盈利，品牌分别是 Neutrogena、WELLAGE、SKIN DEVA、MESANDY。也就是说，最近一批进入者是 0% 成功，而且失败并不是集中在少数弱品牌，而是连大牌/老牌也一起失手，这说明不是“谁更强谁赢”，而是整体竞争在恶化。整体可识别产品中，盈利比例只有 30.77%，新发布的可盈利比例更低到 16.67%，这对新入场者非常不友好。
对两类卖家分别看：大品牌如果硬进，至少要对标 MAREE 的 B0G2CKD7M9，并准备承受更高的品牌、研发和投放成本；但当前数据并没有给出任何稳定的高成功样本可复制。小企业方面，没有看到可靠的真实小品牌成功案例，反而更像是被挤压的环境：Olay 的 B0G31F471Z、Neutrogena 的 B0GY4SY3JF、以及 WELLAGE / SKIN DEVA / MESANDY 的新款都没盈利，且没有显示出“低评论、自然成长”的健康路径。结论很直接：不要进入这个市场；如果一定要做，只能把 MAREE 的 B0G2CKD7M9 视作唯一可参考对象，但这更像高投入案例，不适合把它当成小企业可复制模板。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 1 0 0 0 1 2026 0 0 0 0 0 0 0 4 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 1 2025/12 0 0 0 1 0 0 0 0 2026/1 0 0 0 0 0 0 0 1 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 1 2026/4 0 0 0 0 0 0 0 2 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesNeutrogenaB08936CZHQ (4.5/5 (11705 Reviews))Neutrogena Hydro Boost Night Pressed Serum, 1.7 oz
This listing is deemed profitablePrice (USD)$27.74Released TypeOld Release (2020-07-04)Brand is an old entry in this marketSize and Weight10.4 x 7.4 x 7.3 cm, 181.00gProfitable Factors
Established brand with longevityBased on old ASINDesign & Appearance
压缩罐/按压式膏体包装，区别于常见滴管精华瓶Key Buying Motive
主打夜间压缩式精华霜，强调48小时保湿与修护屏障，兼具透明质酸和抗氧化成分Target Customers
更适合偏干、普通到极干肤质，且偏好夜间修护型保湿霜的人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$55,480.002000 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight34.97% / 36.25%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight31.79% / 33.07%Peak / Non PeakSales & BSR Performance
Organic Hyaluronic Acid Serum for Face | Best Hyaluronic Acid (Oligo) + 4 Hyaluronic Sizes - Highly Dosed | Hydrating Serum - Aging-Aging Moisturizer – Fragrance-Free | Made in Germany
This listing is deemed profitablePrice (USD)$17.17Released TypeOld Release (2023-10-31)Brand is an old entry in this marketSize and Weight12.5 x 4.0 x 3.9 cm, 109.00gProfitable Factors
Based on old ASINDesign & Appearance
琥珀色瓶身搭配金色泵头与棕金包装，偏自然/专业护肤风格, 采用常见滴管精华瓶型，不是明显私模；但外包装强调德国制造与实验室背书Key Buying Motive
4种不同分子大小的透明质酸组合，并叠加泛醇、尿囊素、甜菜碱等保湿修护成分，主打高保湿与温和兼容Target Customers
更适合追求无香精、无酒精、德国制造和皮肤耐受性的人群，以及偏好“高配方纯净保湿”路线的用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$3,434.00200 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight26.67% / 28.26%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight23.57% / 25.16%Peak / Non PeakSales & BSR Performance
Loading samples... 50%